391 related articles for article (PubMed ID: 34012599)
1. Narrative review of metabolomics in cardiovascular disease.
Müller J; Bertsch T; Volke J; Schmid A; Klingbeil R; Metodiev Y; Karaca B; Kim SH; Lindner S; Schupp T; Kittel M; Poschet G; Akin I; Behnes M
J Thorac Dis; 2021 Apr; 13(4):2532-2550. PubMed ID: 34012599
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.
Ussher JR; Elmariah S; Gerszten RE; Dyck JR
J Am Coll Cardiol; 2016 Dec; 68(25):2850-2870. PubMed ID: 28007146
[TBL] [Abstract][Full Text] [Related]
3. Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application.
Kim SH; Weiß C; Hoffmann U; Borggrefe M; Akin I; Behnes M
Curr Pharm Biotechnol; 2017; 18(6):445-455. PubMed ID: 28571562
[TBL] [Abstract][Full Text] [Related]
4. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
Dona AC; Coffey S; Figtree G
Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics of peripheral artery disease.
Ismaeel A; Lavado R; Koutakis P
Adv Clin Chem; 2022; 106():67-89. PubMed ID: 35152975
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases.
Dang VT; Huang A; Werstuck GH
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):166-175. PubMed ID: 29683098
[TBL] [Abstract][Full Text] [Related]
8. Application of Metabolomics to Epidemiological Studies of Atherosclerosis and Cardiovascular Disease.
Iida M; Harada S; Takebayashi T
J Atheroscler Thromb; 2019 Sep; 26(9):747-757. PubMed ID: 31378756
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
Marcinkiewicz-Siemion M; Ciborowski M; Kretowski A; Musial WJ; Kaminski KA
Int J Cardiol; 2016 Sep; 219():156-63. PubMed ID: 27323342
[TBL] [Abstract][Full Text] [Related]
10. 1H NMR-metabolomics: can they be a useful tool in our understanding of cardiac arrest?
Chalkias A; Fanos V; Noto A; Castrén M; Gulati A; Svavarsdóttir H; Iacovidou N; Xanthos T
Resuscitation; 2014 May; 85(5):595-601. PubMed ID: 24513156
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and Metabolomics Insights into Dilated Cardiomyopathy.
Ampong I
Ann Nutr Metab; 2022; 78(3):147-155. PubMed ID: 35472668
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in heart failure: the past, current and future.
Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F
Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637
[TBL] [Abstract][Full Text] [Related]
13. Integrating serum proteomics and metabolomics to compare the common and distinct features between acute aggressive ischemic stroke (APIS) and acute non-aggressive ischemic stroke (ANPIS).
Lai M; Zhang X; Zhou D; Zhang X; Zhu M; Liu Q; Zhang Y; Wang D
J Proteomics; 2022 Jun; 261():104581. PubMed ID: 35421619
[TBL] [Abstract][Full Text] [Related]
14. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
Zhao YY; Cheng XL; Lin RC
Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
[TBL] [Abstract][Full Text] [Related]
15. The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
Mamas M; Dunn WB; Neyses L; Goodacre R
Arch Toxicol; 2011 Jan; 85(1):5-17. PubMed ID: 20953584
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics and Heart Diseases: From Basic to Clinical Approach.
Barba I; Andrés M; Garcia-Dorado D
Curr Med Chem; 2019; 26(1):46-59. PubMed ID: 28990507
[TBL] [Abstract][Full Text] [Related]
17. Application of metabolomics to cardiovascular biomarker and pathway discovery.
Lewis GD; Asnani A; Gerszten RE
J Am Coll Cardiol; 2008 Jul; 52(2):117-23. PubMed ID: 18598890
[TBL] [Abstract][Full Text] [Related]
18. The combined measurement of high-sensitivity cardiac troponins and natriuretic peptides: a useful tool for clinicians?
Perrone MA; Zaninotto M; Masotti S; Musetti V; Padoan A; Prontera C; Plebani M; Passino C; Romeo F; Bernardini S; Clerico A
J Cardiovasc Med (Hagerstown); 2020 Dec; 21(12):953-963. PubMed ID: 33156589
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial.
Karagiannidis E; Sofidis G; Papazoglou AS; Deda O; Panteris E; Moysidis DV; Stalikas N; Kartas A; Papadopoulos A; Stefanopoulos L; Karvounis H; Gika H; Theodoridis G; Sianos G
BMC Cardiovasc Disord; 2021 Feb; 21(1):79. PubMed ID: 33557756
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
